Compare Tianjin TEDA Biomedical Engineering Co. Ltd. with Similar Stocks
Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of -6.24% and Operating profit at -8.63% over the last 5 years
2
Negative results in Dec 25
3
With ROE of 45.33%, it has a Very Expensive valuation with a 14.56 Price to Book Value
4
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
87.5%
0%
87.5%
6 Months
-15.0%
0%
-15.0%
1 Year
-40.0%
0%
-40.0%
2 Years
40.11%
0%
40.11%
3 Years
186.52%
0%
186.52%
4 Years
0%
0%
0.0%
5 Years
-12.07%
0%
-12.07%
Tianjin TEDA Biomedical Engineering Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-6.24%
EBIT Growth (5y)
-8.63%
EBIT to Interest (avg)
5.03
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
3.87
Sales to Capital Employed (avg)
2.85
Tax Ratio
32.95%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3,418.30%
ROE (avg)
1,933.92%
Valuation key factors
Factor
Value
P/E Ratio
32
Industry P/E
Price to Book Value
14.56
EV to EBIT
14.47
EV to EBITDA
9.49
EV to Capital Employed
2.97
EV to Sales
0.61
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
20.52%
ROE (Latest)
45.33%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
567.20
417.90
35.73%
Operating Profit (PBDIT) excl Other Income
-84.10
-23.70
-254.85%
Interest
4.10
5.00
-18.00%
Exceptional Items
-25.10
-2.60
-865.38%
Consolidate Net Profit
-123.10
-41.20
-198.79%
Operating Profit Margin (Excl OI)
-166.30%
-80.40%
-8.59%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 35.73% vs -4.98% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -198.79% vs -240.50% in Dec 2024
About Tianjin TEDA Biomedical Engineering Co. Ltd. 
Tianjin TEDA Biomedical Engineering Co. Ltd.
Chemicals & Petrochemicals
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






